Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Preliminary results
Inv. presentation
Quarterly results
Director departure

Acutus Medical, Inc. (AFIB) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 4 Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.
Txns: Paid exercise price by delivering 433 shares @ $0.69, valued at $298.8
08/07/2023 4 Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.
Txns: Paid exercise price by delivering 134 shares @ $0.69, valued at $92.5
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Quarterly results
Docs: "Acutus Medical Reports Second Quarter 2023 Financial Results"
08/02/2023 4 Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 20,000 shares @ $0
08/02/2023 4 Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns: Paid exercise price by delivering 6,484 shares @ $0
08/02/2023 4 Mukai Takeo (CFO) has filed a Form 4 on Acutus Medical, Inc.
Txns: Paid exercise price by delivering 501 shares @ $0
07/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
06/29/2023 4/A ElBardissi Andrew (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 8,400 shares @ $0
Granted 19,600 options to buy @ $0.8349, valued at $16.4k
06/15/2023 4 Marzouk Shaden (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 8,400 shares @ $0
Granted 19,600 options to buy @ $0.8349, valued at $16.4k
06/15/2023 4 Sheridan John F (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 8,400 shares @ $0
Granted 19,600 options to buy @ $0.8349, valued at $16.4k
06/15/2023 4 Bonita David P (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 8,400 shares @ $0
Granted 19,600 options to buy @ $0.8349, valued at $16.4k
06/15/2023 4 Huennekens R Scott (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 10,920 shares @ $0
Granted 25,480 options to buy @ $0.8349, valued at $21.3k
06/15/2023 4 ElBardissi Andrew (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 8,400 shares @ $0
Granted 19,600 options to buy @ $0.8349, valued at $16.4k
06/15/2023 4 Garland Jason K (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 8,400 shares @ $0
Granted 19,600 options to buy @ $0.8349, valued at $16.4k
06/15/2023 4 Pellegrini Niamh Louise (Director) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 8,400 shares @ $0
Granted 19,600 options to buy @ $0.8349, valued at $16.4k
06/01/2023 4 Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns: Paid exercise price by delivering 17,290 shares @ $0.8479, valued at $14.7k
05/26/2023 SD Form SD - Specialized disclosure report:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "Acutus Medical Reports First Quarter 2023 Financial Results"
05/05/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
04/27/2023 ARS Form ARS - Annual Report to Security Holders:
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/20/2023 8-K Quarterly results
04/04/2023 4 Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.
Txns: Paid exercise price by delivering 321 shares @ $0.754, valued at $242
04/04/2023 4 Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns: Paid exercise price by delivering 3,165 shares @ $0.754, valued at $2.4k
04/04/2023 4 Piscitello Charlie (SVP, Chief People Officer) has filed a Form 4 on Acutus Medical, Inc.
Txns: Paid exercise price by delivering 855 shares @ $0.754, valued at $644.7
04/04/2023 4 Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.
Txns: Paid exercise price by delivering 855 shares @ $0.754, valued at $644.7
03/16/2023 8-K Quarterly results
Docs: "Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results"
03/13/2023 8-K Other Events
03/02/2023 4 Sohn Tom (SVP, Gen. Counsel & Secretary) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 42,500 shares @ $0
Granted 42,500 options to buy @ $1.41, valued at $59.9k
03/02/2023 4 Mathews Kevin (SVP, Commercial) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 42,500 shares @ $0
Granted 42,500 options to buy @ $1.41, valued at $59.9k
03/02/2023 4 Roman David (President & CEO) has filed a Form 4 on Acutus Medical, Inc.
Txns: Granted 135,000 shares @ $0
Granted 135,000 options to buy @ $1.41, valued at $190.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy